Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Robert Ross Carter files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- M33 Growth I L.P. - $20.70M of STLN open-market activity in the last 12 months
- Jorey Chernett - $2.69M of STLN open-market activity in the last 12 months
- Brad Hively - $2.00M of STLN open-market activity in the last 12 months
- Mohit Kaushal - $335K of STLN open-market activity in the last 12 months
- Yale Podnos - $276K of STLN open-market activity in the last 12 months
- Mark L. Pacala - $200K of STLN open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Robert Ross Carter?
Robert Ross Carter is a corporate insider, tracked as Chief Financial Officer of Starling Oncology, Inc. (STLN). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Robert Ross Carter last file a Form 4?
The most recent primary Form 4 on record is dated 22 May 2026, one of 7 filings going back to 2024.
Has Robert Ross Carter been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($879) across all tracked filings.
Where can I see all of Robert Ross Carter's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Robert Ross Carter and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
